Get startedLog in
    Picture of Regulus Therapeutics logo

    RGLS — Regulus Therapeutics News Story

    0.000.00%
    us flag iconLast trade - 00:00
    HealthcareSpeculativeMid CapMomentum Trap
    All News

    Brief: Regulus Therapeutics Reports Fourth Quarter Results

    Picture of Regulus Therapeutics logoRegulus Therapeutics
    23/03/2023 20:10
    March 23 (Reuters) - Regulus Therapeutics Inc  RGLS.O :
    * REGULUS THERAPEUTICS REPORTS FOURTH QUARTER AND YEAR-END
2022
FINANCIAL RESULTS AND RECENT UPDATES
    * REGULUS THERAPEUTICS INC-QTRLY NET LOSS WAS $6.8 MILLION,
OR
$0.40 PER SHARE (BASIC AND DILUTED)

Source text for Eikon:  ID:nPn1qZYvQa 
Further company coverage:  RGLS.O 

 ((Reuters.Briefs@thomsonreuters.com;))

    Recent news on Regulus Therapeutics

    See all news